Drugs / Buprenorphine/naloxone
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01908842 | Aug 2013 → Apr 2014 | opiate dependence | Orexo AB | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Buprenorphine/naloxone | “Buprenorphine/naloxone sublingual tablets” NCT01908842 ↗ |